Continuing his studies at Oxford University, Prof. A study of coronavirus vaccines was conducted under the leadership of Matthew Snape. As a result of the studies, a remarkable effect of the vaccines, which is the most effective weapon against the coronavirus pandemic, was determined. So much so that instead of using the coronavirus vaccine developed by one company, shooting the vaccines developed by different companies provides stronger immunity.
People included in the study conducted in the UK were given the Pfizer-BioNTech or AstraZeneca vaccine as the first dose. The experts, who waited for 9 weeks after the first dose, preferred Moderna as the second dose. As a result of the examinations, it was determined that people who were given vaccines from different companies developed better immunity. In fact, the results were better than the method used with two doses of AstraZeneca.
The global vaccine crisis can be resolved
prof. Matthew Snape spoke to Reuters about their work. “We saw that a very good immune response was developed. Even two doses of AstraZeneca are above the threshold set for …” The scientist, who said, “With his statement, there was hope for the whole world again.
It is an undeniable fact that there are great inequalities in the distribution of coronavirus vaccines. Rich countries stockpiled enough vaccines for their populations months in advance. Among the countries whose financial situation is not good, there are even those who have not met the vaccine. It is believed that the new research will direct countries to different companies, and thus, it will be easier to reach the vaccine. . .
41405
